Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
Authors
Keywords
famotidine, toll-like receptor, SARS-CoV-2, antiviral signaling, histamine
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 297, Issue 2, Pages 100925
Publisher
Elsevier BV
Online
2021-06-30
DOI
10.1016/j.jbc.2021.100925
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
- (2021) Goran Kokic et al. Nature Communications
- The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
- (2021) Madeline Loffredo et al. Scientific Reports
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
- (2020) Tobias Janowitz et al. GUT
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- (2020) Donghyuk Shin et al. NATURE
- Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis
- (2020) Joseph T. Ortega et al. Biomolecules
- Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19
- (2020) Jeffrey F. Mather et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
- (2020) Reed B. Hogan II et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Potential association of mast cells with coronavirus disease 2019
- (2020) Theoharis C. Theoharides ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Modulation of Mast Cell Toll-Like Receptor 3 Expression and Cytokines Release by Histamine
- (2018) Guogang Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease
- (2016) Miklós Békés et al. MOLECULAR CELL
- ZINC 15 – Ligand Discovery for Everyone
- (2015) Teague Sterling et al. Journal of Chemical Information and Modeling
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Physiological implications of biased signaling at histamine H2 receptors
- (2015) Natalia Alonso et al. Frontiers in Pharmacology
- The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity
- (2014) Krystal Matthews et al. Virology Journal
- SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex
- (2014) Xiaojuan Chen et al. Protein & Cell
- Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
- (2012) Chi-Pang Chuck et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Insulin-Dependent Phosphatidylinositol 3-Kinase/Akt and ERK Signaling Pathways Inhibit TLR3-Mediated Human Bronchial Epithelial Cell Apoptosis
- (2011) T. Numata et al. JOURNAL OF IMMUNOLOGY
- SwissDock, a protein-small molecule docking web service based on EADock DSS
- (2011) A. Grosdidier et al. NUCLEIC ACIDS RESEARCH
- Profiling of Substrate Specificity of SARS-CoV 3CLpro
- (2010) Chi-Pang Chuck et al. PLoS One
- A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
- (2008) K. Ratia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started